Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase NA 18Phase 1 12Phase 3 5Phase EARLY_PHASE1 3Phase 2/3 3Phase 1/2 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Radiodermatitis 1Polycystic Ovary Syndrome 1Condylomata Acuminata 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Curcumin × Clear all
NCT07278128 2025-12-11

Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial

Tarbiat Modarres University

Phase 2/3 Completed
74 enrolled

Polycystic Ovary Syndrome

NCT06281353 2024-02-28

The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue

Indonesia University

Phase 2/3 Completed
78 enrolled

Condylomata Acuminata

NCT01246973 2016-03-07

Oral Curcumin for Radiation Dermatitis

University of Rochester

Phase 2/3 Completed
686 enrolled 8 charts

Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡